ReviewFrontiers in immunology2026

Inhibitory receptor states, immune homeostasis and the benefit-risk boundary of cancer checkpoint blockade.

Xiaodong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.